Sponsors (6)
The bill improves patient safety and accountability by setting a ≤1% blood culture contamination standard and creating incentives for better lab practices, but it also imposes costs and reporting burdens that could strain smaller/rural hospitals and create incentives to avoid or game care for high‑risk patients.
Medicare beneficiaries will face a lower risk of harm from contaminated blood cultures because hospitals will be incentivized to reduce contamination rates to ≤1% starting FY2026, reducing false positives, unnecessary treatments, and diagnostic delays.
Hospitals will have stronger financial incentives to invest in better lab practices and infection control, allowing those that reduce contamination to avoid Medicare payment penalties and potentially improve overall care quality.
Hospitals and regulators will gain a clear national standard (≤1% contamination) and comparable reporting, increasing accountability, enabling benchmarking across subsection (d) hospitals, and helping identify facilities that need improvement.
Smaller and rural hospitals will face added costs to meet the ≤1% contamination standard, which could strain budgets and lead to service reductions, consolidation, or closure in affected communities.
Medicare beneficiaries and other high‑risk patients could experience reduced access or altered care if hospitals avoid treating higher‑risk cases or adjust documentation to improve measured contamination rates and evade penalties.
Hospitals and federal agencies will incur additional administrative burden and data‑system costs to implement and report the new measure, increasing paperwork and operational complexity.
Based on analysis of 2 sections of legislative text.
Adds blood culture contamination as a Medicare hospital-acquired condition and requires a contamination measure with a target rate not exceeding 1%, effective FY2026.
Adds blood culture contamination to the list of hospital-acquired conditions used in Medicare payment rules and directs the Secretary to create a contamination measure for certain hospitals. The measure must be based on a blood culture contamination rate that should not exceed 1 percent and the change applies starting with discharges in fiscal year 2026.
Introduced September 10, 2025 by Mike Kelly · Last progress September 10, 2025